NYSEArca - Delayed Quote USD

iShares MSCI EAFE ETF (EFA)

77.70 -0.15 (-0.19%)
At close: April 24 at 4:00 PM EDT
77.38 -0.32 (-0.41%)
After hours: April 24 at 7:55 PM EDT
Loading Chart for EFA
DELL
  • Previous Close 77.85
  • Open 77.97
  • Bid 76.55 x 1300
  • Ask 78.50 x 1100
  • Day's Range 77.39 - 77.97
  • 52 Week Range 65.68 - 80.06
  • Volume 8,502,326
  • Avg. Volume 15,096,543
  • Net Assets 53.38B
  • NAV 77.80
  • PE Ratio (TTM) 14.87
  • Yield 2.81%
  • YTD Daily Total Return 3.32%
  • Beta (5Y Monthly) 1.05
  • Expense Ratio (net) 0.33%

The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The index is a free float-adjusted, market capitalization-weighted index designed to measure large- and mid-capitalization equity market performance of developed markets outside of the U.S. and Canada.

iShares

Fund Family

Foreign Large Blend

Fund Category

53.38B

Net Assets

2001-08-14

Inception Date

Performance Overview: EFA

Trailing returns as of 4/23/2024. Category is Foreign Large Blend.

YTD Return

EFA
3.32%
Category
5.24%
 

1-Year Return

EFA
9.05%
Category
13.54%
 

3-Year Return

EFA
2.52%
Category
2.92%
 

People Also Watch

Holdings: EFA

Top 10 Holdings (15.33% of Total Assets)

SymbolCompany% Assets
NOVO-B.CO
Novo Nordisk A/S 2.44%
ASML.AS
ASML Holding N.V. 2.28%
NESN.SW
Nestlé S.A. 1.67%
7203.T
Toyota Motor Corporation 1.57%
MC.PA
LVMH Moët Hennessy - Louis Vuitton, Société Européenne 1.46%
SHEL.L
Shell plc 1.26%
AZN.L
AstraZeneca PLC 1.23%
SAP.DE
SAP SE 1.20%
NOVN.SW
Novartis AG 1.17%
ROG.SW
Roche Holding AG 1.05%

Sector Weightings

SectorEFA
Industrials   16.71%
Healthcare   12.92%
Technology   10.18%
Energy   4.19%
Utilities   2.88%
Real Estate   2.39%

Related ETF News

Research Reports: EFA

  • Analyst Report: Biogen Inc.

    Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation antibody Gazyva are marketed via a collaboration with Roche. Biogen also markets novel multiple sclerosis drugs Plegridy, Tysabri, Tecfidera, and Vumerity. In Japan, Biogen's MS portfolio is copromoted by Eisai. Hemophilia therapies Eloctate and Alprolix (partnered with Sobi) were spun off as part of Bioverativ in 2017. Biogen's newer products include Spinraza (SMA, with partner Ionis), Leqembi (Alzheimers, with partner Eisai), Skyclarys (Friedreich's Ataxia, Reata), Zurzuvae (post-partum depression, Sage), and Qalsody (ALS, Ionis). Biogen has several drug candidates in phase 3 trials in neurology-related fields.

    Rating
    Price Target
     
  • Analyst Report: Netflix, Inc.

    Netflix’s relatively simple business model involves only one business, its streaming service. It has the biggest television entertainment subscriber base in both the United States and the collective international market, with almost 250 million subscribers globally. Netflix has exposure to nearly the entire global population outside of China. The firm has traditionally avoided live programming or sports content, instead focusing on on-demand access to episodic television, movies, and documentaries. The firm recently began introducing ad-supported subscription plans, giving the firm exposure to the advertising market in addition to the subscription fees that have historically accounted for nearly all its revenue.

    Rating
    Price Target
     
  • Analyst Report: Berkshire Hathaway Inc.

    Berkshire Hathaway is a holding company with a wide array of subsidiaries engaged in diverse activities. The firm's core business segment is insurance, run primarily through Geico, Berkshire Hathaway Reinsurance Group, and Berkshire Hathaway Primary Group. Berkshire has used the excess cash thrown off from these and its other operations over the years to acquire Burlington Northern Santa Fe (railroad), Berkshire Hathaway Energy (utilities and energy distributors), and the firms that make up its manufacturing, service, and retailing operations (which include five of Berkshire's largest noninsurance pretax earnings generators: Precision Castparts, Lubrizol, Clayton Homes, Marmon, and IMC/ISCAR). The conglomerate is unique in that it is run on a completely decentralized basis.

    Rating
    Price Target
     
  • Analyst Report: Meta Platforms, Inc.

    Meta is the world’s largest online social network, with nearly 4 billion family of apps monthly active users. Users engage with each other in different ways, exchanging messages and sharing news events, photos, and videos. The firm’s ecosystem consists mainly of the Facebook app, Instagram, Messenger, WhatsApp, and many features surrounding these products. Users can access Facebook on mobile devices and desktops. Advertising revenue represents more than 90% of the firm’s total revenue, with more than 45% coming from the U.S. and Canada and over 20% from Europe.

    Rating
    Price Target
     

Related Tickers